The National Institute of Allergy and Infectious Diseases (NIAID) recently announced promising results from a small but important study involving 30 recovered COVID-19 patients infected…
Recent research from the Washington University School of Medicine in St. Louis suggests that dangerous, new, fast spreading SARS-CoV-2 variants can avoid antibodies that work…
A research team from the Broad institute, the University of British Columbia and 4Fusion Genomics Corporation have developed an open, free public browser resource for tracking COVID-19 virus…
Moderna Inc. (Nasdaq: MRNA), the biotechnology company with one of the authorized vaccines for COVID-19, completed the manufacturing of clinical trial material for its variant-specific…
In a January 25 piece in the New York Times, “As Virus Grows Stealthier, Vaccine Makers Reconsider Battle Plans,” they posit that the Moderna and…
TrialSite has reported that the two approved COVID-19 vaccines in the U.S. (Moderna and Pfizer/BioNTech) lose some of their effectiveness against the South African SARS-CoV-2…
Three possibly more dangerous and transmissible coronavirus strains are spreading throughout the United States now from the United Kingdom (UK), Brazil and now South Africa.…
Moderna announced the results from in vitro neutralization studies of sera from individuals vaccinated with Moderna COVID-19 Vaccine showing activity against emerging strains of SARS-CoV-2.…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
